Purchase this article with an account.
J. A. Donnelly, E. B. Moses, E. M. Miglino, L. F. Jindra; Five Year Experience of Effect of Race on Selective Laser Trabeculoplasty as Therapy in Patients With Glaucoma. Invest. Ophthalmol. Vis. Sci. 2009;50(13):157.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To examine the effect of Selective Laser Trabeculoplasty (SLT) on intraocular pressure (IOP) as primary and secondary therapy in glaucoma patients of varying ethnicity.
Retrospective chart review was performed on 1403 eyes from a consecutive case series of 2056 eyes treated with SLT over 5 years. Eyes were divided into those treated with primary and secondary therapy, then subdivided by race: Black and White. Mean decrease in IOP and change in meds after treatment with SLT was recorded and analyzed.
In eyes which had SLT as primary treatment, Blacks and Whites showed an average IOP drop of 28% and 27% respectively. In eyes which had SLT as secondary treatment, Blacks and Whites showed an average IOP drop of 24% and 23%, respectively; analysis of the change in medication post-SLT showed that Blacks and Whites showed an average decrease in meds of 54% and 33%, respectively. Results were significant (p<0.01).
In this study, the mean IOP drops after primary SLT for Blacks and Whites were not significantly different; mean IOP drops after secondary SLT for Blacks and Whites were not significantly different (p<0.01). The mean decrease in meds after secondary SLT for Blacks and Whites were significantly different, with Blacks having a larger mean decrease in meds than Whites (p<0.01).
This PDF is available to Subscribers Only